Hemorrhoid. Hemorrhoids and perianal venous thrombosis
Conditions
Interventions
Intervention 1: Intervention group: Calmex suppository (produced by Tabib-Daru Pharmaceutical Company, containing oak placenta extract from Quercus infectoria plant, essential oil from Myrtus communis
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18 to 60 years old A definite diagnosis of hemorrhoids by a specialist doctor Hemorrhoids with grade 1 and 2 severity The patient must have a written informed and free consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients with thrombosed external hemorrhoids Patients with strangulated internal hemorrhoids Patients with anal fistula Patients with anal fissure Patients with anal abscess Pregnancy Patients with portal hypertension Patients with malignancy Patients with kidney failure Patients with grade 3 and 4 hemorrhoids Having a history of allergic reaction The occurrence of a severe allergic reaction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rectal bleeding. Timepoint: Days 0 and 14. Method of measurement: Clinical examination.;Heaviness of the anus. Timepoint: Days 0 and 14. Method of measurement: Question from the patient.;Itching of the anus. Timepoint: Days 0 and 14. Method of measurement: Question from the patient.;Anus burning. Timepoint: Days 0 and 14. Method of measurement: Question from the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Days 0 and 14. Method of measurement: Question from the patient and clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFereshteh Dehdar
Bagheiat-allah University of Medical Sciences
Outcome results
None listed